ApoE isoform-specific effects on LTP: Blockade by oligomeric amyloid-β1-42

Neurobiology of Disease

Volumn 18, Issue 1, 2005, Pages 75-82

  Trommer, Barbara L ^a,b,c,f   Shah, Chirag ^c   Yun, Sung Hwan ^a,b,c   Gamkrelidze, Georgi ^a,b,c   Pasternak, Emily S ^c   Blaine Stine, W ^c   Manelli, Arlene ^c   Sullivan, Patrick ^d   Pasternak, Joseph F ^a,b,c   LaDu, Mary Jo ^a,c,e  

^a UNIVERSITY OF CHICAGO   (United States)

^b Division of Neurology   (United States)

^c ENH Research Institute   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e Division of Geriatrics   (United States)

^f EVANSTON NORTHWESTERN HEALTHCARE   (United States)

Author keywords

A oligomers; Alzheimer disease; Amyloid ; ApoE; ApoE transgenic mice; Dentate gyrus; Hippocampal slices; Long term potentiation (LTP); Neuroplasticity

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; ISOPROTEIN;

ANIMAL TISSUE; ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; HIPPOCAMPUS; KNOCKOUT MOUSE; LONG TERM POTENTIATION; MALE; MEMORY; MODEL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN INTERACTION; RISK ASSESSMENT; TISSUE SLICE;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; CELL SURVIVAL; HIPPOCAMPUS; LONG-TERM POTENTIATION; MALE; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; MOLECULAR WEIGHT; NEUROPROTECTIVE AGENTS; ORGAN CULTURE TECHNIQUES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN ISOFORMS;

EID: 19944429503     PISSN: 09699961     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nbd.2004.08.011     Document Type: Article

References (71)

1. K.R. Bales, T. Verina, R.C. Dodel, Y. Du, L. Altstiel, M. Bender, P. Hyslop, E.M. Johnstone, S.P. Little, D.J. Cummins, P. Piccardo, B. Ghetti, and S.M. Paul Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition Nat. Genet. 17 1997 263 264
2. S.W. Barger, and M.P. Mattson Isoform-specific modulation by apolipoprotein E of the activities of secreted beta-amyloid precursor protein J. Neurochem. 69 1997 60 67
3. M. Buttini, M. Orth, S. Bellosta, H. Akeefe, R.E. Pitas, T. Wyss-Coray, L. Mucke, and R.W. Mahley Expression of human apolipoprotein E3 or E4 in the brains of Apoe-/- mice: isoform-specific effects on neurodegeneration J. Neurosci. 19 1999 4867 4880
4. M. Buttini, G.Q. Yu, K. Shockley, Y. Huang, B. Jones, E. Masliah, M. Mallory, T. Yeo, F.M. Longo, and L. Mucke Modulation of Alzheimer-like synaptic and cholinergic deficits in transgenic mice by human apolipoprotein E depends on isoform, aging, and overexpression of amyloid beta peptides but not on plaque formation J. Neurosci. 22 2002 10539 10548
5. K. Cambon, H.A. Davies, and M.G. Stewart Synaptic loss is accompanied by an increase in synaptic area in the dentate gyrus of aged human apolipoprotein E4 transgenic mice Neuroscience 97 2000 685 692
6. D.B. Carter, E. Dunn, D.D. McKinley, N.C. Stratman, T.P. Boyle, S.L. Kuiper, J.A. Oostveen, R.J. Weaver, J.A. Boller, and M.E. Gurney Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain Ann. Neurol. 50 2001 468 475
7. P.F. Chapman, G.L. White, M.W. Jones, D. Cooper-Blacketer, V.J. Marshall, M. Irizarry, L. Younkin, M.A. Good, T.V. Bliss, B.T. Hyman, S.G. Younkin, and K.K. Hsiao Impaired synaptic plasticity and learning in aged amyloid precursor protein transgenic mice Nat. Neurosci. 2 1999 271 276
8. Q.S. Chen, B.L. Kagan, Y. Hirakura, and C.W. Xie Impairment of hippocampal long-term potentiation by Alzheimer amyloid beta-peptides J. Neurosci. Res. 60 2000 65 72
9. Q.S. Chen, W.Z. Wei, T. Shimahara, and C.W. Xie Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus Neurobiol. Learn. Mem. 77 2002 354 371
10. E.H. Corder, A.M. Saunders, N.J. Risch, W.J. Strittmatter, D.E. Schmechel, P.C. Gaskell Jr., J.B. Rimmler, P.A. Locke, P.M. Conneally, and K.E. Schmader Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease Nat. Genet. 7 1994 180 184
11. W.K. Cullen, Y.H. Suh, R. Anwyl, and M.J. Rowan Block of LTP in rat hippocampus in vivo by beta-amyloid precursor protein fragments NeuroReport 8 1997 3213 3217
12. K.N. Dahlgren, A.M. Manelli, W.B. Stine Jr., L.K. Baker, G.A. Krafft, and M.J. LaDu Oligomeric and fibrillar species of amyloid-beta peptides differentially affect neuronal viability J. Biol. Chem. 277 2002 32046 32053
13. S. Deb, J. Braganza, N. Norton, H. Williams, P.G. Kehoe, J. Williams, and M.J. Owen APOE epsilon 4 influences the manifestation of Alzheimer's disease in adults with Down's syndrome Br. J. Psychiatry 176 2000 468 472
14. B. Drouet, A. Fifre, M. Pincon-Raymond, J. Vandekerckhove, M. Rosseneu, J.L. Gueant, J. Chambaz, and T. Pillot ApoE protects cortical neurones against neurotoxicity induced by the non-fibrillar C-terminal domain of the amyloid-beta peptide J. Neurochem. 76 2001 117 127
15. F.J. Ekinci, K.U. Malik, and T.B. Shea Activation of the L voltage-sensitive calcium channel by mitogen-activated protein (MAP) kinase following exposure of neuronal cells to beta-amyloid. MAP kinase mediates beta-amyloid-induced neurodegeneration J. Biol. Chem. 274 1999 30322 30327
16. K.C. Evans, E.P. Berger, C.G. Cho, K.H. Weisgraber, and P.T. Lansbury Jr. Apolipoprotein E is a kinetic but not a thermodynamic inhibitor of amyloid formation: implications for the pathogenesis and treatment of Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 763 767
17. S.M. Greenberg, J.P. Vonsattel, A.Z. Segal, R.I. Chiu, A.E. Clatworthy, A. Liao, B.T. Hyman, and G.W. Rebeck Association of apolipoprotein E epsilon2 and vasculopathy in cerebral amyloid angiopathy Neurology 50 1998 961 965
18. S. Grehan, E. Tse, and J.M. Taylor Two distal downstream enhancers direct expression of the human apolipoprotein E gene to astrocytes in the brain J. Neurosci. 21 2001 812 822
19. J. Hardy, and D.J. Selkoe The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics Science 297 2002 353 356
20. R.E. Hartman, H. Laurer, L. Longhi, K.R. Bales, S.M. Paul, T.K. McIntosh, and D.M. Holtzman Apolipoprotein E4 influences amyloid deposition but not cell loss after traumatic brain injury in a mouse model of Alzheimer's disease J. Neurosci. 22 2002 10083 10087
21. M.J. Hoffer, M.H. Hofker, M.M. van Eck, L.M. Havekes, and R.R. Frants Evolutionary conservation of the mouse apolipoprotein e-c1-c2 gene cluster: structure and genetic variability in inbred mice Genomics 15 1993 62 67
22. D.M. Holtzman, K.R. Bales, T. Tenkova, A.M. Fagan, M. Parsadanian, L.J. Sartorius, B. Mackey, J. Olney, D. McKeel, D. Wozniak, and S.M. Paul Apolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 97 2000 2892 2897
23. A.Y. Hsia, E. Masliah, L. McConlogue, G.-Q. Yu, G. Tatsuno, K. Hu, D. Kholodenko, R.C. Malenka, R.A. Nicoll, and L. Mucke Plaque-independent disruption of neural circuits in Alzheimer's disease mouse models Proc. Natl. Acad. Sci. U. S. A. 96 1999 3228 3233
24. M.C. Irizarry, B.S. Cheung, G.W. Rebeck, S.M. Paul, K.R. Bales, and B.T. Hyman Apolipoprotein E affects the amount, form, and anatomical distribution of amyloid beta-peptide deposition in homozygous APP(V717F) transgenic mice Acta Neuropathol. (Berl.) 100 2000 451 458
25. M.C. Irizarry, G.W. Rebeck, B. Cheung, K. Bales, S.M. Paul, D. Holzman, and B.T. Hyman Modulation of A beta deposition in APP transgenic mice by an apolipoprotein E null background Ann. N. Y. Acad. Sci. 920 2000 171 178
26. D. Ji, R. Lape, and J.A. Dani Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity Neuron 31 2001 131 141
27. K. Jin, A.L. Peel, X.O. Mao, L. Xie, B.A. Cottrell, D.C. Henshall, and D.A. Greenberg Increased hippocampal neurogenesis in Alzheimer's disease Proc. Natl. Acad. Sci. U. S. A. 101 2004 343 347
28. B.D. Jordan, N.R. Relkin, L.D. Ravdin, A.R. Jacobs, A. Bennett, and S. Gandy Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing JAMA 278 1997 136 140
29. J. Jordan, M.F. Galindo, R.J. Miller, C.A. Reardon, G.S. Getz, and M.J. LaDu Isoform-specific effect of apolipoprotein E on cell survival and beta-amyloid-induced toxicity in rat hippocampal pyramidal neuronal cultures J. Neurosci. 18 1998 195 204
30. D.E. Kang, C.U. Pietrzik, L. Baum, N. Chevallier, D.E. Merriam, M.Z. Kounnas, S.L. Wagner, J.C. Troncoso, C.H. Kawas, R. Katzman, and E.H. Koo Modulation of amyloid beta-protein clearance and Alzheimer's disease susceptibility by the LDL receptor-related protein pathway J. Clin. Invest. 106 2000 1159 1166
31. M.D. Kirkitadze, G. Bitan, and D.B. Teplow Paradigm shifts in Alzheimer's disease and other neurodegenerative disorders: the emerging role of oligomeric assemblies J. Neurosci. Res. 69 2002 567 577
32. W.L. Klein, G.A. Krafft, and C.E. Finch Targeting small Abeta oligomers: the solution to an Alzheimer's disease conundrum? Trends Neurosci. 24 2001 219 224
33. M.J. LaDu, M.T. Falduto, A.M. Manelli, C.A. Reardon, G.S. Getz, and D.E. Frail Isoform-specific binding of apolipoprotein E to beta-amyloid J. Biol. Chem. 269 1994 23403 23406
34. 1-42 are potent central nervous system neurotoxins Proc. Natl. Acad. Sci. U. S. A. 95 1998 6448 6453
35. T.A. Lanz, D.B. Carter, and K.M. Merchant Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype Neurobiol. Dis. 13 2003 246 253
36. J.R. Lynch, W. Tang, H. Wang, M.P. Vitek, E.R. Bennett, P.M. Sullivan, D.S. Warner, and D.T. Laskowitz APOE genotype and an ApoE-mimetic peptide modify the systemic and central nervous system inflammatory response J. Biol. Chem. 278 2003 48529 48533
37. A.M. Manelli, W.B. Stine, L.J. Van Eldik, and M.J. LaDu ApoE and Abeta1-42 Interactions: effects of isoform and conformation on structure and function J. Mol. Neurosci. 23 2004 235 246
38. M.-M. Mesulam Neuroplasticity failure in Alzheimer's disease: bridging the gap between plaques and tangles Neuron 24 1999 521 529
39. M. Miyata, and J.D. Smith Apolipoprotein E allele-specific antioxidant activity and effects on cytotoxicity by oxidative insults and beta-amyloid peptides Nat. Genet. 14 1996 55 61
40. 1-42 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation J. Neurosci. 20 2000 4050 4058
41. J. Naslund, V. Haroutunian, R. Mohs, K.L. Davis, P. Davies, P. Greengard, and J.D. Buxbaum Correlation between elevated levels of amyloid beta-peptide in the brain and cognitive decline JAMA 283 2000 1571 1577
42. J.A. Nicoll, G.W. Roberts, and D.I. Graham Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury Nat. Med. 1 1995 135 137
43. J.J. Palop, B. Jones, L. Kekonius, J. Chin, G.Q. Yu, J. Raber, E. Masliah, and L. Mucke Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits Proc. Natl. Acad. Sci. U. S. A. 100 2003 9572 9577
44. J. Poirier, M.C. Delisle, R. Quirion, I. Aubert, M. Farlow, D. Lahiri, S. Hui, P. Bertrand, J. Nalbantoglu, and B.M. Gilfix Apolipoprotein E4 allele as a predictor of cholinergic deficits and treatment outcome in Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 92 1995 12260 12264
45. T. Polvikoski, R. Sulkava, M. Haltia, K. Kainulainen, A. Vuorio, A. Verkkoniemi, L. Niinisto, P. Halonen, and K. Kontula Apolipoprotein E, dementia, and cortical deposition of beta-amyloid protein N. Engl. J. Med. 333 1995 1242 1247
46. Z. Qiu, K.A. Crutcher, B.T. Hyman, and G.W. Rebeck ApoE isoforms affect neuronal N-methyl-d-aspartate calcium responses and toxicity via receptor-mediated processes Neuroscience 122 2003 291 303
47. J. Raber, D. Wong, G.Q. Yu, M. Buttini, R.W. Mahley, R.E. Pitas, and L. Mucke Apolipoprotein E and cognitive performance Nature 404 2000 352 354
48. C.R. Raymond, D.R. Ireland, and W.C. Abraham NMDA receptor regulation by amyloid-beta does not account for its inhibition of LTP in rat hippocampus Brain Res. 968 2003 263 272
49. G.W. Rebeck, M. Kindy, and M.J. LaDu Apolipoprotein E and Alzheimer's disease: the protective effects of ApoE2 and E3 J. Alzheimer's Dis. 4 2002 145 154
50. G.W. Rebeck, J.S. Reiter, D.K. Strickland, and B.T. Hyman Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions Neuron 11 1993 575 580
51. A.M. Saunders Apolipoprotein E and Alzheimer disease: an update on genetic and functional analyses J. Neuropathol. Exp. Neurol. 59 2000 751 758
52. S.W. Scheff, and D.A. Price Synaptic pathology in Alzheimer's disease: a review of ultrastructural studies Neurobiol. Aging 24 2003 1029 1046
53. D.J. Selkoe Alzheimer's disease: genes, proteins, and therapy Physiol. Rev. 81 2001 741 766
54. D.J. Selkoe Alzheimer's disease is a synaptic failure Science 298 2002 789 791
55. D.H. Small The amyloid cascade hypothesis debate: emerging consensus on the role of A beta and amyloid in Alzheimer's disease The Sixth International Conference on Alzheimer's Disease Amyloid vol. 5 1998 Amsterdam The Netherlands 301 304 July
56. W.B. Stine Jr., K.N. Dahlgren, G.A. Krafft, and M.J. LaDu In vitro characterization of conditions for amyloid-beta peptide oligomerization and fibrillogenesis J. Biol. Chem. 278 2003 11612 11622
57. W.J. Strittmatter, A.M. Saunders, D. Schmechel, M. Pericak-Vance, J. Enghild, G.S. Salvesen, and A.D. Roses Apolipoprotein E: high-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease Proc. Natl. Acad. Sci. U. S. A. 90 1993 1977 1981
58. P.M. Sullivan, H. Mezdour, Y. Aratani, C. Knouff, J. Najib, R.L. Reddick, S.H. Quarfordt, and N. Maeda Targeted replacement of the mouse apolipoprotein E gene with the common human APOE3 allele enhances diet-induced hypercholesterolemia and atherosclerosis J. Biol. Chem. 272 1997 17972 17980
59. Y. Sun, S. Wu, G. Bu, M.K. Onifade, S.N. Patel, M.J. LaDu, A.M. Fagan, and D.M. Holtzman Glial fibrillary acidic protein-apolipoprotein E (apoE) transgenic mice: astrocyte-specific expression and differing biological effects of astrocyte-secreted apoE3 and apoE4 lipoproteins J. Neurosci. 18 1998 3261 3272
60. Y. Tatebayashi, M.H. Lee, L. Li, K. Iqbal, and I. Grundke-Iqbal The dentate gyrus neurogenesis: a therapeutic target for Alzheimer's disease Acta Neuropathol. (Berl.) 105 2003 225 232
61. I. Tesseur, J. van Dorpe, K. Spittaels, H.C. Van Den, D. Moechars, and F. Van Leuven Expression of human apolipoprotein E4 in neurons causes hyperphosphorylation of protein tau in the brains of transgenic mice Am. J. Pathol. 156 2000 951 964
62. B. Teter, J. Raber, B. Nathan, and K.A. Crutcher The presence of apoE4, not the absence of apoE3, contributes to AD pathology J. Alzheimers. Dis. 4 2002 155 163
63. M. Tolar, J.N. Keller, S. Chan, M.P. Mattson, M.A. Marques, and K.A. Crutcher Truncated apolipoprotein E (ApoE) causes increased intracellular calcium and may mediate ApoE neurotoxicity J. Neurosci. 19 1999 7100 7110
64. F. Trinchese, S. Liu, F. Battaglia, S. Walter, P.M. Mathews, and O. Arancio Progressive age-related development of Alzheimer-like pathology in APP/PS1 mice Ann. Neurol. 55 2004 801 814
65. D.M. Walsh, I. Klyubin, J.V. Fadeeva, W.K. Cullen, R. Anwyl, M.S. Wolfe, M.J. Rowan, and D.J. Selkoe Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo Nature 416 2002 535 539
66. X.S. Wang, and E. Gruenstein Rapid elevation of neuronal cytoplasmic calcium by apolipoprotein E peptide J. Cell. Physiol. 173 1997 73 83
67. H.Y. Wang, D.H. Lee, M.R. D'Andrea, P.A. Peterson, R.P. Shank, and A.B. Reitz beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology J. Biol. Chem. 275 2000 5626 5632
68. H.W. Wang, J.F. Pasternak, H. Kuo, H. Ristic, M.P. Lambert, B. Chromy, K.L. Viola, W.L. Klein, W.B. Stine, G.A. Krafft, and B.L. Trommer Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus Brain Res. 924 2002 133 140
69. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe, and R. Anwyl Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5 J. Neurosci. 24 2004 3370 3378
70. T. Wisniewski, E.M. Castano, A. Golabek, T. Vogel, and B. Frangione Acceleration of Alzheimer's fibril formation by apolipoprotein E in vitro Am. J. Pathol. 145 1994 1030 1035
71. Y. Zhu, and D.Y. Hui Apolipoprotein E binding to low density lipoprotein receptor-related protein-1 inhibits cell migration via activation of cAMP-dependent protein kinase A J. Biol. Chem. 278 2003 36257 36263